Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamibarotene in Advanced Hepatocellular Carcinoma
NCT00731445Phase 2Completed
- Sponsor
- Zeria Pharmaceutical Co., Ltd.
- Start
- Jul 2008
- Primary completion
- Jan 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of tamibarotene in hepatocellular carcinoma (HCC), sponsored by Zeria Pharmaceutical Co., Ltd.. Started Jul 2008; status: completed.
02
Drugs
tamibarotene
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00731445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00731445.